Top

Tag: Pharmaceuticals


Clinical Trials, Research and Development

Driving clinical trial innovation forward with precision medicine

January 17, 2023

Via: Pharmaphorum

Unify, launched in December 2020, is AstraZeneca’s patient app and clinical trial support tool. Already, it is operating at scale across the company, used in more than 28 countries and available in 62 languages. Dissecting heterogeneity To begin discussions, pharmaphorum […]


Biotech, Industry, Pharma

European Health Data Space (EHDS) update: what this means for pharmaceutical and biotech

January 4, 2023

Via: Pharmaphorum

The intention is to streamline the process for patients wishing to access their medical records via electronic health record systems (“EHR systems”) and to facilitate the ability for researchers, innovators, and policy makers to use the data in a trusted […]


Industry, Pharma

Supporting the era of green pharmaceuticals in the UK

November 29, 2022

Via: Pharmaphorum

‘Supporting the era of green pharmaceuticals in the UK’ highlights that, while Britain can play a leading role in the sustainability agenda for pharmaceuticals, action must also be taken on a global scale to ensure impact. The pharmaceutical industry’s share […]


Clinical Trials, Research and Development

X Chromosome Inactivation Surprisingly Found in Diverse Cancers in Men

November 10, 2022

Via: GEN

Cancer cells acquire genetic changes that allow them to grow and proliferate unchecked. Researchers at the Dana-Faber Cancer Institute and colleagues have now found another difference between cancer cells and normal cells. The team analyzed public datasets comprising thousands of […]


Industry, Pharma

How pharma can thrive in the digital era

November 3, 2022

Via: Pharmaphorum

Beyond digital clinical measures, digital solutions are maturing to address major challenges facing clinical research and offer enormous promise to support the key performance indicators (KPIs) for every member of our industry. We see how digital measures of adherence ensure […]


News

5 questions facing drugmakers as third quarter earnings begin

October 17, 2022

Via: Biopharma Dive

Beginning this week, pharmaceutical executives will be on the spot as they reveal their companies’ earnings for the first time since major drug pricing legislation was enacted in the U.S. The law was a significant defeat for the industry, but […]


FDA, Regulations

FDA Approves Botox Competitor That Lasts Longer

September 9, 2022

Via: Drugs.com

People wanting to keep wrinkles at bay will soon have a new option now that the U.S. Food and Drug Administration has approved the first competitor for Botox in decades. Daxxify, made by Revance Therapeutics Inc. in Nashville, Tenn., is […]


Industry, Pharma

Pharma’s climate change vulnerability and opportunity

September 9, 2022

Via: Pharmaphorum

Pharma’s reliance on global supply chains and its need for vast quantities of water make it particularly vulnerable to climate change. But preparing to adapt to the phenomenon presents an opportunity as well as a challenge. Rising global temperatures will, […]


Industry, Pharma

Now is the time for pharma to help solve bias in clinical trials

September 7, 2022

Via: Pharmaphorum

The industry’s application of mRNA techniques during the pandemic led to the fastest vaccine development in history. The processes used are now seeing huge infrastructure commitments, in order to cement their place in the development of future products and trials. […]


Mergers and Acquisitions

Aptar Pharma Acquires Metaphase Design Group

September 6, 2022

Via: Contract Pharma

Aptar Pharma, a leader in drug delivery and active material science solutions and services, has acquired Metaphase Design Group Inc., a leader in applying the science of human factors engineering and ergonomics to product design. The acquisition expands Aptar Pharma’s […]


Mergers and Acquisitions

Neurocrine Bio agrees $57m takeover of UK biotech Diurnal

August 30, 2022

Via: Pharmaphorum

The 27.5 pence-a-share cash deal values Diurnal at around £48.3 million ($57 million), a 144% premium to the biotech’s closing share price on Friday. Shares in the UK firm had leaped 132% to 26.1 pence at the time of writing […]


Manufacturing, Research and Development

ADHD Drug Adderall in Short Supply

August 29, 2022

Via: Drugs.com

Labor shortages at Teva Pharmaceuticals have made Adderall, a widely used attention-deficit/hyperactivity disorder (ADHD) drug, hard to find in some drugstores. But the U.S. Food and Drug Administration noted that there’s no overall shortage of ADHD medications. Only Teva is […]


FDA, Regulations

Thousands of U.S. Patients Got COVID Treatments Rejected as Useless by FDA

August 29, 2022

Via: Drugs.com

U.S. doctors administered more than 150,000 doses of useless monoclonal antibody treatments to COVID-19 patients early this year, spending loads of cash on therapies that had been deemed of no benefit, a new study has found. The U.S. Food and […]


Manufacturing, Mergers and Acquisitions, Research and Development

ElevateBio and the Univ. of Pittsburgh Enter Biomanufacturing Partnership

August 26, 2022

Via: Contract Pharma

ElevateBio and the University of Pittsburgh have entered into a long-term partnership to accelerate the development of cell and gene therapies. Through this agreement, ElevateBio will locate one of its next BaseCamp process development and Good Manufacturing Practice (GMP) manufacturing […]


Industry, Vaccines

AI-derived cancer vaccines: the pharmaphorum podcast

August 25, 2022

Via: Pharmaphorum

Today on the pharmaphorum podcast, Editor in Chief Jonah Comstock welcomes Hedi Ben Brahim and Eric Quéméneur, CEO and chief science officer respectively of Transgene, to discuss cancer vaccines in general and Transgene’s recent work in the space in particular. […]


Clinical Trials, Research and Development

To build diversity into clinical trials, collaborate at the community level

August 24, 2022

Via: Pharmaphorum

Removing barriers to clinical trial participation for underserved groups is an essential part of addressing health inequalities. Getting there, however, is easier said than done. The Food and Drug Administration’s (FDA) draft guidance, Diversity Plans to Improve Enrollment of Participants […]


Industry, Vaccines

Next-generation RNA technologies: making longer-lasting drugs with a broader reach

August 23, 2022

Via: Biopharma Dive

The key ingredient in the coronavirus vaccines developed by Moderna and BioNTech doesn’t last very long. Once in the body, this messenger RNA, or mRNA, degrades within days. Still, that’s enough time for the vaccines to train the body to […]


Mergers and Acquisitions

Aerie’s glaucoma drug journey ends in $770M sale to Alcon

August 23, 2022

Via: Biopharma Dive

Alcon has agreed to acquire Aerie Pharmaceuticals for about $770 million, betting its sprawling commercial presence can boost the uptake of the biotechnology company’s two glaucoma drugs. Alcon, the former eyecare business of Swiss pharmaceutical giant Novartis, will pay $15.25 […]


Clinical Trials, Research and Development

Jazz Pharmaceuticals’ epilepsy drug advances into phase 3 trial

August 22, 2022

Via: Pharma Times

The phase 3 trials will assess Epidiolex over 14 weeks in a randomised, double-blind, placebo-controlled study, enrolling paediatric patients aged one to 18. It is hoped that Epidiolex will ease symptoms associated with Doose syndrome (EMAS), a rarer type of […]


Industry, Vaccines

EU advisors back lower monkeypox jab dose to stretch supplies

August 22, 2022

Via: Pharmaphorum

The recommendation comes after a review of a clinical trial which found that delivering a smaller dose intradermally – just below the top layer of the skin – is as effective as giving the standard dose subcutaneously as recommended on […]